Main public logs

Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).

• 19:35, 13 June 2024 CHoppe talk contribs created page Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study (Created page with "{{Reference |Reference=Publication: Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study }} =Brief summary= The study investigated 100 patients with head and neck carcinoma who were treated with radiotherapy. Fifty percent of the patients were randomly assigned to a group receiving daily zinc, while the other half received a placebo made of soybean oil. The study observed the t...")
• 19:17, 13 June 2024 CHoppe talk contribs created page Publication: Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study (Created page with "{{Publication |Title=Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study |Topic=Zinc |Author=Lin, L-C;Que, J; Lin, L-K; Lin, F-C |Year=2006 |Journal=International journal of radiation oncology, biology, physics |DOI=doi:10.1016/j.ijrobp.2006.01.015 |Authors Abstract=Purpose: To determine whether zinc supplementation can accelerate the healing of mucositis and dermatitis after...")
• 18:17, 13 June 2024 CHoppe talk contribs created page Iovino et al. (2018): High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation (Created page with "{{Reference |Reference=Publication: High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation }} =Brief summary= The study by Iovino et al. focused on investigating various preclinical data related to immune system parameters following hematopoietic stem cell transplantation. Of 18 patients, 9 were given zinc sulfate after the transplantation, and the patients' blood was subseq...")
• 18:11, 13 June 2024 CHoppe talk contribs created page Publication: High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation (Created page with "{{Publication |Title=High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation |Topic=Zinc |Author=Iovino, L; Mazziotta, F; Carulli, G; Guerrini, F; Morganti, R; Mazzotti, V; Maggi, F; Macera, L; Orciuolo, E; Buda, G; Benedetti, E; Caracciolo, F; Galimberti, S; Pistello, M; Petrini, M |Year=2018 |Journal=Leukemia Research |DOI=https://doi.org/10.1016/j.leukres.2018.04.016 |Auth...")
• 13:57, 13 June 2024 CHoppe talk contribs created page Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) (Created page with "{{Reference |Reference=Publication: Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteri...")
• 13:55, 13 June 2024 CHoppe talk contribs created page Publication: Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) (Created page with "{{Publication |Title=Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) |Topic=Zinc |Author=Halyard, MY; Jatoi, A; Sloan, JA; Bearden, JD; Vora, SA; Atherton, PJ; Perez, EA; Soori, G; Zalduendo, AC; Zhu, A; Stella, PJ; Loprinzi, CL |Year=2007 |Journal=International journal of radiation oncology, biology, physics |DOI...")
• 08:27, 13 June 2024 CMensger talk contribs created page Publication: Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics (Created page with "{{Publication |Title=Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics |Topic=Resveratrol |Author=Howells, LM; Berry, DP; Elliott, PJ; Jacobson, EW; Hoffmann, E; Hegarty, B; Brown, K; Steward, WP; Gescher, AJ |Year=2011 |Journal=Cancer Prevention Research |DOI=10.1158/1940-6207.CAPR-11-0148 |Authors Abstract=The phytochemical resveratrol has undergone extensiv...")
• 07:52, 13 June 2024 JDoerfler talk contribs created page Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Reference |Reference=Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countri...")
• 07:49, 13 June 2024 JDoerfler talk contribs created page Publication: Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology (Created page with "{{Publication |Title=Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology |Topic=Selenium |Author=Muecke, R; Schomburg, L; Glatzel, M; Berndt-Skorka, R; Baaske, D; Reichl, B; Buentzel, J; Kundt, G; Prott, FJ; Devries, A; Stoll, G; Kisters, K; Bruns, F; Schaefer, U; Willich, N; Micke, O |Year=2010 |Journal=International Journal of Radiation Oncology – Biology – Physics |DOI=doi:10.1016/j.ijrobp.2009.08.013 |A...")
• 07:03, 13 June 2024 DDeel talk contribs created page Jyothirmayi et al. (1996), Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer (Created page with "{{Reference |Reference=Publication: Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer }} =Brief summary= In this study, two groups of patients with head and neck cancer were compared whereby one group received a common synthetic vitamin A preparation for one year and the other group only a placebo. The study investigated whether the two groups differed over a period of three years with regard to the frequency...")
• 06:31, 13 June 2024 DDeel talk contribs created page Publication: Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer (Created page with "{{Publication |Title=Efficacy of Vitamin A in the Prevention of Locoregional Recurrence and Second Primaries in Head and Neck Cancer |Topic=Vitamin A (beta-carotene) |Author=Jyothirmayi, R; Ramadas, K; Varghese, C; Jacob, R; Nair, M; Sankaranarayanan, R |Year=1996 |Journal=European journal of cancer. |DOI=https://doi.org/10.1016/S0964-1955(96)00010-3 |Authors Abstract=Chemoprevention with retinoids is currently an experimental approach to prevent local relapses and secon...")
• 08:38, 12 June 2024 MKraft talk contribs created page Paur et al. (2017): Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA (Created page with "{{Reference |Reference=Publication: Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA }} =Brief summary= In this well-conducted study, prostate cancer patients were divided into one of three groups three weeks before their planned prostate removal or radiotherapy. The first group was to consume a minimum amount of tomato products daily, the second group was to additionally consume other products such as green tea, pomegranate and grape j...")
• 08:30, 12 June 2024 MKraft talk contribs created page Publication: Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA (Created page with "{{Publication |Title=Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA |Topic=Lycopene |Author=Paur, I.; Lilleby, W.; Bøhn, S. K.; Hulander, E.; Klein, W.; Vlatkovic, L.; Axcrona, K.; Bolstad, N.; Bjøro, T.; Laake, P.; Taskén, K. A.; Svindland, A.; Eri, L. M.; Brennhovd, B.; Carlsen, M. H.; Fosså, S. D.; Smeland, S. S.; Karlsen, A. S.; Blomhoff, R. |Year=2017 |Journal=Clinical Nutrition |DOI=https://doi.org/10.1016/j.clnu.2016.06.014...")
• 15:07, 11 June 2024 MKraft talk contribs created page Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients (Created page with "{{Reference |Reference=Publication: Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients }} =Brief summary= In this study, a large sample of 120 cancer patients who had received cisplatin chemotherapy was examined. Half of the patients received lycopene in addition to chemotherapy and standard treatment to prevent kidney damage. Neither the participants nor the study leaders knew who was also receiving lycopene. The values recorded to deter...")
• 14:56, 11 June 2024 MKraft talk contribs created page Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients (Created page with "{{Reference |Reference=Publication: Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients }} =Brief summary= In this study, a large sample of 120 cancer patients who had received cisplatin chemotherapy was examined. Half of the patients received lycopene in addition to chemotherapy and standard treatment to prevent kidney damage. Neither the participants nor the study leaders knew who was also receiving lycopene. The values recorded to deter...")
• 14:47, 11 June 2024 MKraft talk contribs created page Publication: Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients (Created page with "{{Publication |Title=Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients |Topic=Lycopene |Author=Mahmoodnia, L.; Mohammadi, K.; Masumi, R. |Year=2017 |Journal=Journal of nephropathology |DOI=https://doi.org/10.15171/jnp.2017.25 |Authors Abstract=Background: Nephrotoxicity is one of the most important limitations of cisplatin-based chemotherapies which associated with many complications and high mortality rate. Objectives: To investigate...")
• 14:14, 11 June 2024 JDoerfler talk contribs created page Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Reference |Reference=Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
• 14:10, 11 June 2024 MKraft talk contribs created page Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer (Created page with "{{Reference |Reference=Publication: Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer }} =Brief summary= This study compared three groups of patients, all of whom had prostate cancer and were on an active surveillance program. They were given a lycopene tablet (15mg), a fish oil tablet or a matching placebo twice a day for 3 months. The “prostate specific antigen” (PSA) is an important indicator of the development o...")
• 14:04, 11 June 2024 MKraft talk contribs created page Publication: Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer (Created page with "{{Publication |Title=Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer |Topic=Lycopene |Author=Chan, J.; Weinberg, V.; Magbanua, M.; Sosa, E.; Simko, J.; Shinohara, K.; Federman, S.; Mattie, M.; Hughes-Fulford, M.; Haqq, C.; Carroll, P. |Year=2011 |Journal=Cancer Causes Control |DOI=https://doi.org/10.1007/s10552-010-9684-5 |Authors Abstract=Background: Nutritional factors are associated with reduced risk of prostate ca...")
• 14:03, 11 June 2024 JDoerfler talk contribs created page Publication: Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck (Created page with "{{Publication |Title=Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck |Topic=Selenium |Author=Mix, M; Singh, AK; Tills, M; Dibaj, S; Groman, A; Jaggernauth, W; Rustum, Y; Jameson, M B |Year=2015 |Journal=World journal of clinical oncology |DOI=10.5306/wjco.v6.i5.166 |Authors Abstract=AIM: To investigate whether selenomethionine (SLM) reduces mucositis incidence in patie...")
• 11:15, 11 June 2024 DDeel talk contribs created page Ehrenpreis et al. (2005), A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy (Created page with "{{Reference |Reference=Publication: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Speci...")
• 11:14, 11 June 2024 DDeel talk contribs created page Publication: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy (Created page with "{{Publication |Title=A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy |Topic=Vitamin A (beta-carotene) |Author=Ehrenpreis, E; Jani, A; Levitsky, J; Ahn, J; Hong, J |Year=2005 |Journal=Diseases of the Colon & Rectum |DOI=10.1007/s10350-004-0821-7 |Authors Abstract=PURPOSE: This study was designed to determine whether oral retinol palmitate (vitamin A) can reduce the symptomsof...")
• 06:54, 11 June 2024 JDoerfler talk contribs created page Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Reference |Reference=Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N r...")
• 13:17, 10 June 2024 JDoerfler talk contribs created page Publication: Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 (Created page with "{{Publication |Title=Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 |Topic=Selenium |Author=Karp, D. D.; Lee, S. J.; Keller, S. M.; Wright, G. S.; Aisner, S.; Belinsky, S. A.; Johnson, D. H.; Johnston, M. R.; Goodman, G.; Clamon, G.; Okawara, G.; Marks, R.; Frechette, E.; McCaskill-Stevens, W.; Lippman, S. M.; Ruckdeschel, J.; Khuri, F. R. |Y...")
• 12:41, 10 June 2024 DDeel talk contribs deleted page Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial (content was: "{{Publication |Title=Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial |Topic=Vitamin C |Author=Jeon, Y; Park, J; Moon, S; Yeo, J |Year=2016 |Journal=Pain Research and Management |DOI=http://dx.doi.org/10.1155/2016/9147279 |Authors Abstract=Background and Objective. Vitamin C has antioxidant,...", and the only contributor was "Cotto" (talk))
• 12:38, 10 June 2024 DDeel talk contribs created page Publication: Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial (Created page with "{{Publication |Title=Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial |Topic=Vitamin C |Author=Jeon, Y; Park, J; Moon, S; Yeo, J |Year=2016 |Journal=Pain Research and Management |DOI=http://dx.doi.org/10.1155/2016/9147279 |Authors Abstract=Background and Objective. Vitamin C has antioxidant, neuroprotective, and neuromodulating effects. Recently, it showed antinociceptive effect a...")
• 12:31, 10 June 2024 DDeel talk contribs created page Publication: 00 Test page (Created page with "{{Publication |Title=Test page |Topic=? |Author=Test author |Year=-999 |Journal=- |DOI=- |Authors Abstract=? }}")
• 12:30, 10 June 2024 DDeel talk contribs created page 00 Test page (Created page with "{{Reference |Reference=Publication: 00_Test page }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Character...")
• 12:28, 10 June 2024 DDeel talk contribs deleted page Probeseite (content was: "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Ou...", and the only contributor was "DDeel" (talk))
• 12:28, 10 June 2024 DDeel talk contribs created page Probeseite (Created page with "{{Reference |Reference=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |Countries of data collection=? |LoE=? |Outcome timeline=? }} =Characteristics of participants= {{Characteristics of participants |...")
• 08:25, 10 June 2024 JDoerfler talk contribs created page Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Reference |Reference=Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analy...")
• 08:22, 10 June 2024 JDoerfler talk contribs created page Publication: The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial (Created page with "{{Publication |Title=The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial |Topic=Selenium |Author=Jahangard-Rafsanjani, Z.; Gholami, K.; Hadjibabaie, M.; Shamshiri, A.R.; Alimoghadam, K.; Sarayani, A.; Mojtahedzadeh, M.; Ostadali-Dehaghi, M.; Ghavamzadeh, A. |Year=2013 |Journal=Bone marrow transplantation |DOI=10.1038/bmt.2012.250 |Authors Abstract=Oral mucositis (OM) is a complication of high-dose...")
• 11:26, 7 June 2024 JDoerfler talk contribs deleted page Tj (content was: "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}", and the only contributor was "JDoerfler" (talk))
• 11:25, 7 June 2024 JDoerfler talk contribs created page Tj (Created page with "{{Publication |Title=xfj |Topic=FactorAF2 |Author=hf |Year=2015 |Journal=cgj |Authors Abstract=Background }}")
• 11:24, 7 June 2024 JDoerfler talk contribs created page Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Reference |Reference=Publication: Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N rand...")
• 10:46, 7 June 2024 JDoerfler talk contribs created page Publication: Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial (Created page with "{{Publication |Title=Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial |Topic=Selenium |Author=Goossens, M.E.; Zeegers, M.P.; van Poppel, H.; Joniau, S.; Ackaert, K.; Ameye, F.; Billiet, I.; Braeckman, J.; Breugelmans, A.; Darras, J.; Dilen, K.; Goeman, L.; Tombal, B.; Van Bruwaene, S.; Van Cleyenbreugel, B.; Van der Aa, F.; Vekemans, K.; Buntinx, F. |Year=2016 |Journal=E...")
• 10:19, 7 June 2024 DDeel talk contribs deleted page Van Deel (2024), Löschen (content was: "{{Publication |Title=Löschen |Topic=Angelica sinensis, Zeolites |Author=Dana van Deel |Year=2024 |Journal=Wichtig |DOI=wichtig.de |Authors Abstract=? }}", and the only contributor was "DDeel" (talk))
• 10:18, 7 June 2024 DDeel talk contribs deleted page SR by Jacobs et al. (2015), Vitamin C (content was: "{{Publication |Title=Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review |Topic=Vitamin C |Author=Jacobs, C; Hutton, B; Ng, T; Shorr, R; Clemons, M. |Year=2015 |Journal=The Oncologist |DOI=http://dx.doi.org/10.1634/theoncologist.2014-0381 |Authors Abstract=Background. Many cancer patients receive supplementa...", and the only contributor was "JDoerfler" (talk))
• 10:18, 7 June 2024 DDeel talk contribs deleted page Publicationlöschen (content was: "{{Publication |Title=testitel |Topic=Agaricus |Author=1212 |Year=1111 |Journal=asdddd |DOI=asdsd |Authors Abstract=?hier steht jetzt text }}", and the only contributor was "Cotto" (talk))
• 10:18, 7 June 2024 DDeel talk contribs deleted page Publication name without commas (content was: "{{Publication |Title=Titel |Topic=Aloe vera |Author=Hans, Peter |Year=2018 |Journal=asd |DOI=asd.de }}", and the only contributor was "Cotto" (talk))
• 10:17, 7 June 2024 DDeel talk contribs deleted page Otto et al., 2019, Understanding, categorizing and predicting semantic image-text relations (content was: "{{Publication |Topic=NI |Title=Understanding, categorizing and predicting semantic image-text relations |Author=Christian Otto; Matthias Springstein; Avishek Anand; Ralph Ewerth |Year=2019 |Journal=International Conference on Multimedia Retrieval |DOI=https://doi.org/10.1145/3323873.3325049 |Authors Abstract=Ich bin ein Beispielabstract }}", and the only contributor was "Cotto" (talk))
• 10:16, 7 June 2024 DDeel talk contribs deleted page Mustermann (2024): Effects of Trying too hard (content was: "{{Publication |Title=Effects of Trying too hard |Topic=Amygdalin |Author=Mustermann |Year=2024 |Journal=- |DOI=google.de }}", and the only contributor was "DDeel" (talk))
• 10:16, 7 June 2024 DDeel talk contribs deleted page Löscherino (content was: "{{Publication |Title=a |Topic=Aloe vera |Author=dasdasd |Year=1111 |Journal=dasd |DOI=ddd |Authors' Abstract=?asssssssdddddddddddddddddddddddddddddddddddddddddd }}", and the only contributor was "Cotto" (talk))
• 10:15, 7 June 2024 DDeel talk contribs deleted page Löhöschen (content was: "{{Publication |Title=TestPaper |Topic=Astragalus |Author=Christian Otto |Year=1111 |Journal=qsdasd |DOI=asdasd |Authors Abstract=?dddddddassssssssssssssssss }}", and the only contributor was "Cotto" (talk))
• 10:15, 7 June 2024 DDeel talk contribs deleted page A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality (content was: "{{Publication |Title=A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality |Topic=Vitamin D |Author=Hackshaw-McGeagh, L |Year=2015 |Journal=Cancer Causes and Control |DOI=https://link.springer.com/article/10.1007/s10552-015-0659-4 |Authors Abstract=Purpose Given the long-term, although potenti...", and the only contributor was "Cotto" (talk))
• 10:14, 7 June 2024 DDeel talk contribs deleted page 1Jeon (2016): Vitamin C (content was: "{{Publication |Title=Effect of intravenous high dose Vitamin C on postoperative pain and morphine use after laparoscopic colectomy: A randomized controlled trial. |Topic=Vitamin C |Author=Younghoon Jeon; Jun Seok Park; Suyoung Moon; Jinseok Yeo |Year=2016 |Journal=Pain Research and Management |DOI=http://dx.doi.org/10.1155/2016/9147279 |Authors Abstract=Background and Objective. Vit...", and the only contributor was "DDeel" (talk))
• 09:31, 7 June 2024 JDoerfler talk contribs created page Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Reference |Reference=Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specific...")
• 09:29, 7 June 2024 JDoerfler talk contribs created page Publication: Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients (Created page with "{{Publication |Title=Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients |Topic=Selenium |Author=Büntzel, J.; Riesenbeck, D.; Glatzel, M.; Berndt-Skorka, R.; Riedel, T.; Mücke, R.; Kisters, K.; Schönekaes, K.G.; Schäfer, U.; Bruns, F.; Micke, O. |Year=2010 |Journal=Anticancer research |Authors Abstract=Objective: The substitution of selenium activates the selenium-dependent enzy...")
• 12:53, 6 June 2024 Cotto talk contribs created page Property:Order number (Created a property of type Number)
• 07:33, 4 June 2024 JDoerfler talk contribs created page Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients (Created page with "{{Reference |Reference=Publication: Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=? |Specifications on analyses=? |...")